Skip to main content
Equibles

THEMISMED · Themis Medicare Limited · Financials

Use THEMISMED with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research THEMISMED.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
101.50 INR -0.62 (-0.61%) At close · Nov 13
Rebalance outlook locked
Volume · Nov 13 4731 Avg daily vol (3M) 16.27K

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →
Revenue
3.42B -15.6%
FY2026 Revenue FY2018–FY2026
Net Income
11.44M -96.2%
FY2026 Net Income FY2018–FY2026
Operating Cash Flow
-32.65M -109.4%
FY2026 Operating Cash Flow FY2022–FY2026

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item TTM FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2018
INR 3.32B 3.42B 4.06B 3.82B 3.54B 3.95B 2.31B 2.02B 2.12B
INR 103.1M 103.21M 99.29M 122.46M 104.95M 94.8M 85.47M 82.72M 74.15M
INR 111.96M 106.89M 100.4M 93.77M 95.64M 87.75M 127.13M 128.8M 118.67M
INR 146.15M 7.85M 98.42M 99.2M 156.14M 223.81M 56.28M 20.93M 1.02M
INR 399.75M 11.44M 298.33M 435.24M 569.01M 728.81M 357.03M 247.82M 112.97M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 223.61M in dividends.

Debt Profile

No verified debt profile is available yet. This does not establish that the company has no debt or covenants.